Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shinghwa Advanced Material Group, formerly known as Shandong Shinghwa Chemical Group, is a leading Chinese specialty chemical company that plays a vital role in the pharmaceutical supply chain as a manufacturer of high-purity intermediates. While the company is globally recognized for its dominant position in the lithium-ion battery electrolyte solvent market, it produces a range of carbonate-based chemicals, including dimethyl carbonate and propylene carbonate, which are used as essential solvents and reagents in the synthesis of active pharmaceutical ingredients (APIs). Headquartered in Dongying, Shandong, and listed on the Shanghai Stock Exchange, Shinghwa operates state-of-the-art manufacturing facilities that adhere to rigorous quality standards. The company's expansion into advanced materials and fine chemicals has positioned it as a key supplier for both the green energy and life sciences sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shinghwa Advanced Material Group.